Clinical trial / 2014
Consumption of commercial and fresh orange juice decreased inflammatory markers and increased apo A-1 in healthy volunteers.
Twenty-two healthy volunteers participated in a randomized crossover trial comparing 4 weeks of commercial orange juice (COJ) and 4 weeks of fresh orange juice (FOJ). Consumption of both juices decreased VCAM, hs-CRP, and E-selectin, while increasing apo A-1 levels. Additionally, a decline in LDL was observed in the FOJ group, with the largest variations overall occurring in hs-CRP and VCAM in both groups.
- Study type
- Single-blind randomized crossover controlled trial
- Who was studied
- 22 healthy volunteers
- What was measured
- Flow-mediated dilation, lipids, apolipoproteins A and B, and inflammatory markers (VCAM-1, E-selectin, hs-CRP, IL-6)
THE PAPER
Effect of fresh orange juice intake on physiological characteristics in healthy volunteers.
Asgary S, Keshvari M, Afshani MR, Amiri M, Laher I, Javanmard SH. ISRN Nutr, 2014.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.